Related Experiment Video
Updated: Jul 2, 2026

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
Published on: February 10, 2023
Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk
Pooja Khatri1, Joseph P Broderick, Jane C Khoury
1Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, Ohio 45267-0525, USA. pooja.khatri@uc.edu
Insights
Microcatheter contrast injections (MCIs) during stroke treatment may increase the risk of intracranial hemorrhage (ICH). Minimizing MCIs during intra-arterial revascularization is recommended to reduce potential complications.
Area of Science:
- Neurointerventional radiology
- Cerebrovascular disease management
- Stroke treatment outcomes
Background:
- Intra-arterial revascularization for stroke utilizes contrast injections for visualization.
- Neurointerventionalists exhibit variability in employing microcatheter contrast injections (MCIs).
Purpose of the Study:
- To investigate whether MCIs are a risk factor for intracranial hemorrhage (ICH).
- To assess the association between MCIs and ICH in patients receiving combined intravenous/intra-arterial therapy for stroke.
Main Methods:
- Retrospective analysis of 98 arteriograms from the Interventional Management of Stroke (IMS) I and II trials.
- Quantification of MCIs administered at or beyond the occlusion site.
- Review of postprocedure CT scans for contrast extravasation and ICH, with specific definitions for each.
Main Results:
- The overall rate of ICH was 58% in the studied IMS subset.
- A higher number of MCIs was observed in patients with ICH (median 2 vs. 1, P=0.04).
- MCIs demonstrated a significant association with increased ICH rates (P=0.03) and contrast extravasation, even in multivariable analysis.
Conclusions:
- MCIs may pose a risk for ICH in stroke patients undergoing combined therapy, potentially due to contrast toxicity or pressure effects.
- Minimizing the use of MCIs during intra-arterial revascularization is advised.
- Prospective validation of these findings is planned for the IMS III trial.
Background And Purpose:
During intra-arterial revascularization, either guide catheter injections of contrast in the neck or microcatheter contrast injections (MCIs) at or beyond the site of an occlusion, can be used to visualize intracranial vasculature. Neurointerventionalists vary widely in their use of MCIs for a given circumstance. We tested the hypothesis that MCIs are a risk factor for intracranial hemorrhage (ICH) in the Interventional Management of Stroke (IMS) I and II trials of combined intravenous/IA recombinant tissue plasminogen activator therapy.
Methods:
All arteriograms with M1, M2, and ICA terminus occlusions were reanalyzed (n=98). The number of MCIs within or distal to the target occlusion was assigned. Postprocedure CTs were reviewed for contrast extravasation and ICH. Contrast extravasation was defined as a hyperdensity suggestive of contrast (Hounsfield unit >90) seen at 24 hours or present before 24 hours and persisting or replaced by ICH at 24 hours.
Results:
In this IMS subset, the rate of any ICH was 58% (57 of 98). More MCIs were seen in the ICH group (median=2 versus 1; P=0.04). Increased MCIs were associated with higher ICH rates (P=0.03). MCIs remained associated with ICH in multivariable analysis (P=0.01) as did baseline CT edema/mass effect, atrial fibrillation, time to intravenous recombinant tissue plasminogen activator initiation, and Thrombolysis in Cerebral Infarction reperfusion score. MCIs were also associated with contrast extravasation in unadjusted and adjusted analyses.
Conclusions:
MCIs may risk ICH in the setting of combined intravenous/intra-arterial recombinant tissue plasminogen activator therapy, possibly due to contrast toxicity or pressure transmission by injections. MCIs should be minimized whenever possible. These findings will be tested prospectively in the IMS III trial.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies VII: Vascular Imaging
Venous Thrombosis III: Interprofessional Care
Cardiac Catheterization IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Imaging Studies III: Computed Tomography

